Cargando…

Is Cenobamate the Breakthrough We Have Been Wishing for?

Close to one-third of patients with epilepsies are refractory to current anti-seizure medications; however, trials with cenobamate suggest effectiveness in such patients with focal onset seizures. We searched for data published or otherwise reported on cenobamate and outlined these here. Despite bei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Specchio, Nicola, Pietrafusa, Nicola, Vigevano, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431677/ https://www.ncbi.nlm.nih.gov/pubmed/34502246 http://dx.doi.org/10.3390/ijms22179339

Ejemplares similares

Treatment with Cenobamate in Adult Patients with Lennox–Gastaut Syndrome: A Case Series
por: Falcicchio, Giovanni, et al.
Publicado: (2022)

POLG1-Related Epilepsy: Review of Diagnostic and Therapeutic Findings
por: Specchio, Nicola, et al.
Publicado: (2020)

Changing Times for CLN2 Disease: The Era of Enzyme Replacement Therapy
por: Specchio, Nicola, et al.
Publicado: (2020)

Autism and Epilepsy in Patients With Tuberous Sclerosis Complex
por: Specchio, Nicola, et al.
Publicado: (2020)

Neurophysiological Findings in Neuronal Ceroid Lipofuscinoses
por: Trivisano, Marina, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on pediatric patients with epilepsy – The caregiver perspective
por: Trivisano, Marina, et al.
Publicado: (2020)

Imbalance of Systemic Redox Biomarkers in Children with Epilepsy: Role of Ferroptosis
por: Petrillo, Sara, et al.
Publicado: (2021)

We have been warned
Publicado: (2003)

Refractory Status Epilepticus in Genetic Epilepsy—Is Vagus Nerve Stimulation an Option?
por: Specchio, Nicola, et al.
Publicado: (2020)

Critical care - where have we been and where are we going?
por: Vincent, Jean-Louis
Publicado: (2013)

Male contraception: where are we going and where have we been?
por: Reynolds-Wright, John Joseph, et al.
Publicado: (2019)

Telemedicine in Urology: Where Have We Been and Where Are We Heading?
por: Symeonidis, Evangelos N., et al.
Publicado: (2023)

“I Wish I Had Help Earlier. We Could Have Been Happier Sooner.” Overcoming the Bystander Effect in the Care for Alcohol-Dependent Parents
por: Snoek, Anke, et al.
Publicado: (2021)

Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults
por: Zaccara, Gaetano, et al.
Publicado: (2021)

Have we been operating safely in 2015?
por: Wollmann, D, et al.
Publicado: (2016)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations
por: Schmitz, Bettina, et al.
Publicado: (2023)

Depression in Diabetes: Have We Been Missing Something Important?
por: Gonzalez, Jeffrey S., et al.
Publicado: (2011)

Functional genomics and rheumatoid arthritis: where have we been and where should we go?
por: Jarvis, James N, et al.
Publicado: (2010)

Self-management in heart failure: where have we been and where should we go?
por: Gardetto, Nancy Jean
Publicado: (2011)

The Role of KRAS Mutations in Cortical Malformation and Epilepsy Surgery: A Novel Report of Nevus Sebaceous Syndrome and Review of the Literature
por: Pepi, Chiara, et al.
Publicado: (2021)

Cenobamate for treatment-resistant focal seizures: current evidence and place in therapy
por: Singh, Alok
Publicado: (2022)

Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature
por: Rissardo, Jamir Pitton, et al.
Publicado: (2023)

Spine Surgery Assisted by Augmented Reality: Where Have We Been?
por: Liu, Yanting, et al.
Publicado: (2022)

Craniofacial genetics: Where have we been and where are we going?
por: Weinberg, Seth M., et al.
Publicado: (2018)

The Alphavirus Exit Pathway: What We Know and What We Wish We Knew
por: Brown, Rebecca S., et al.
Publicado: (2018)

Research on Service-Learning in Physical Activity and Sport: Where We Have Been, Where We Are, Where We Are Going
por: Francisco-Garcés, Xavier, et al.
Publicado: (2022)

The 50th anniversary of the Italian League against epilepsy (Lega Italiana Contro l’Epilessia)()
por: Tassi, Laura, et al.
Publicado: (2022)

2020 the year we wish never was
por: Scruth, Elizabeth
Publicado: (2021)

Interaction between Insects, Toxins, and Bacteria: Have We Been Wrong So Far?
por: Tetreau, Guillaume
Publicado: (2018)

Paradigm Shifts in Cardiac Pacing: Where Have We Been and What Lies Ahead?
por: Ballantyne, Brennan A., et al.
Publicado: (2023)

Sequencing Technologies and Analyses: Where Have We Been and Where Are We Going?
por: Bansal, Vikas, et al.
Publicado: (2019)

Correction: Male contraception: where are we going and where have we been?
Publicado: (2020)

Have we been qualifying measurable residual disease correctly?
por: Feng, Yahui, et al.
Publicado: (2023)

The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
por: Löscher, Wolfgang, et al.
Publicado: (2021)

Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)
por: Kasteleijn- Nolst Trenite, Dorothee G.A., et al.
Publicado: (2019)

An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes
por: Ferrari, Louis, et al.
Publicado: (2020)

Onset of efficacy and adverse events during Cenobamate titration period
por: Steinhoff, Bernhard J., et al.
Publicado: (2022)

Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
por: Makridis, Konstantin L., et al.
Publicado: (2022)

Biology Past and Biology Future: Where have we been and where are we going
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u1k7on0u2dcugrqnmosmjg3gem